CREDIT SUISSE AG/ - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$326,955
-60.0%
137,376
-19.6%
0.00%
-100.0%
Q2 2023$818,046
+17.5%
170,782
+39.1%
0.00%0.0%
Q1 2023$696,220
+1.3%
122,790
+0.0%
0.00%0.0%
Q4 2022$687,473
-8.2%
122,763
+5.3%
0.00%0.0%
Q3 2022$749,000
+142.4%
116,619
+29.1%
0.00%
Q2 2022$309,000
-50.0%
90,359
+4.1%
0.00%
-100.0%
Q1 2022$618,000
-10.7%
86,827
+4.5%
0.00%
Q4 2021$692,000
+114.2%
83,053
+78.8%
0.00%
Q3 2021$323,000
-68.3%
46,454
+8.5%
0.00%
-100.0%
Q2 2021$1,020,000
+3.3%
42,810
-10.7%
0.00%0.0%
Q1 2021$987,000
-65.4%
47,913
-58.9%
0.00%0.0%
Q4 2020$2,854,000
+2670.9%
116,518
+727.6%
0.00%
Q1 2018$103,000
-2.8%
14,079
+34.3%
0.00%
Q4 2017$106,000
-68.3%
10,483
-49.8%
0.00%
Q3 2017$334,000
+163.0%
20,867
+85.4%
0.00%
Q2 2017$127,000
-54.5%
11,253
-59.9%
0.00%
Q4 2016$279,000
-12.0%
28,096
+9.2%
0.00%
Q3 2016$317,000
-31.8%
25,731
+60.8%
0.00%
-100.0%
Q2 2016$465,000
+83.1%
16,001
+66.7%
0.00%
Q1 2016$254,000
-16.2%
9,596
+11.1%
0.00%
Q4 2015$303,000
-65.0%
8,639
-70.4%
0.00%
-100.0%
Q3 2015$865,00029,1780.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 14,378,802$342,935,0004.38%
SILVERARC CAPITAL MANAGEMENT, LLC 122,700$2,926,0001.30%
COMMODORE CAPITAL LP 145,453$3,469,0001.21%
Asymmetry Capital Management, L.P. 63,259$1,509,0001.04%
Opaleye Management Inc. 250,000$5,963,0000.99%
Ikarian Capital, LLC 500,000$11,924,0000.96%
HighVista Strategies LLC 44,750$1,068,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 63,915$1,524,0000.68%
Altium Capital Management LP 104,626$2,495,0000.58%
Integral Health Asset Management, LLC 75,000$1,789,0000.49%
View complete list of SERES THERAPEUTICS INC shareholders